日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

他汀类药物显著增强氨基肽酶抑制剂对(耐药性)人类急性髓系白血病细胞的活性

Gerrit Jansen, Marjon Al, Yehuda G Assaraf, Sarah Kammerer, Johan van Meerloo, Gert J Ossenkoppele, Jacqueline Cloos, Godefridus J Peters

Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters

通过靶向组蛋白甲基化来重编程驱动耐药性髓系白血病持续细胞存活的转录状态

Noortje van Gils ,Han J M P Verhagen ,Michaël Broux ,Tania Martiáñez ,Fedor Denkers ,Eline Vermue ,Arjo Rutten ,Tamás Csikós ,Sofie Demeyer ,Meryem Çil ,Marjon Al ,Jan Cools ,Jeroen J W M Janssen ,Gert J Ossenkoppele ,Renee X Menezes ,Linda Smit

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

髓系白血病细胞对氨基肽酶抑制剂前药 CHR2863 的多因素耐药性:羧酸酯酶 1 的下调、脂质滴中的药物封存以及促存活的 ERK/Akt/mTOR 激活

Sue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, Sarah Kammerer, Durga M S H Chandrupatla, Richard Honeywell, Rene P J Musters, Elisa Giovannetti, Tom O'Toole, George L Scheffer, David Krige, Tanja D de Gruijl, Hans W M Niessen, Willem F Lems, Pieternella A Kramer, Rik J Scheper, Jacqueline Cloos, 

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

通过抗 CD20/利妥昔单抗介导的补体依赖性细胞毒性和基于环氧酮的不可逆蛋白酶体抑制剂克服人类 B 细胞对硼替佐米的耐药性

Sue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, Denise Niewerth, Johan van Meerloo, Jacqueline Cloos, Michael van der Veer, George L Scheffer, Godefridus J Peters, Elena T Chan, Janet L Anderl, Christopher J Kirk, Sonja Zweegman, Ben Ac Dijkmans, Willem F Lems, Rik J Scheper, Tanja D de Gruijl, Ge